MedPath

A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.

Not Applicable
Conditions
Health Condition 1: F840- Autistic disorder
Registration Number
CTRI/2023/06/054257
Lead Sponsor
CognitiveBotics Technologies Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Children diagnosed ASD using assessment scales such as

Childhood Autism Rating Scales (CARS)

2. Children with 2 to 18 years

3. Children with associated comorbidities will be included as long as the child is able to use the tool.

4. Ability to understand and respond to instructions given in English

5. Access to a device on which the software can be accessed using internet connection.

6. Parents who have consented for their child to use the software.

Exclusion Criteria

1. Children with intellectual disability with IQ score <50.

2. Parents who are not willing to consent to the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Ability to use the software & follow online instructions by the child & parents <br/ ><br>2. Ability to log childâ??s day to day progress automatically and provide visual graphical feedback on the dashboard <br/ ><br>3. Ability to measure the efficacy of the software, <br/ ><br>a. The childâ??s performance captured by the software at baseline T1 and at T2 <br/ ><br>b. We are comparing to proxy gold standard Clinical scales given below for progress at T1 and T2 <br/ ><br>i. Childhood Autism Rating Scale (CARS), <br/ ><br>ii. ATEC Autism Treatment Evaluation Checklist <br/ ><br>iii. VB MAPP <br/ ><br>c. Parent ILP checklist â?? at baseline T1 and end of the study T2Timepoint: Throughout the study
Secondary Outcome Measures
NameTimeMethod
â?¢To examine if the increase in the number of hours spent on the tool is corelated to the changes in the scores of the scales at T1 & T2.Timepoint: Throughout the study
© Copyright 2025. All Rights Reserved by MedPath